0001607062-18-000343.txt : 20181015 0001607062-18-000343.hdr.sgml : 20181015 20181015161428 ACCESSION NUMBER: 0001607062-18-000343 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170117 FILED AS OF DATE: 20181015 DATE AS OF CHANGE: 20181015 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ro Andrew CENTRAL INDEX KEY: 0001755880 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-25169 FILM NUMBER: 181122367 MAIL ADDRESS: STREET 1: 10102 USA TODAY WAY CITY: MIRAMAR STATE: FL ZIP: 33025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENEREX BIOTECHNOLOGY CORP CENTRAL INDEX KEY: 0001059784 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 820490211 STATE OF INCORPORATION: DE FISCAL YEAR END: 0731 BUSINESS ADDRESS: STREET 1: 10102 USA TODAY WAY CITY: MIRAMAR STATE: FL ZIP: 33025 BUSINESS PHONE: 416-364-2551 MAIL ADDRESS: STREET 1: 10102 USA TODAY WAY CITY: MIRAMAR STATE: FL ZIP: 33025 3 1 ownership.xml X0206 3 2017-01-17 0 0001059784 GENEREX BIOTECHNOLOGY CORP GNBT 0001755880 Ro Andrew 10102 USA TODAY WAY MIRAMAR FL 33025 1 1 0 0 Chief Investment Officer & SVP No Securities are benefically owned 0 D /s/ Gary A. Miller as Attorney-in-Fact 2018-10-15